That model suggested that promoting histone acetylation while simultaneously slowing cAMP degradation could help in restoring L-LTP, which is impaired in mouse models of Rubinstein-Taybi syndrome, a condition resulting in lower levels of CREB binding protein, which reduces transcription. The gene discussed is CREB1; the disease is Rubinstein-Taybi syndrome.